The global aminopiperidine market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for pharmaceutical intermediates and chemical reagents in various industries such as food & beverage, textile, and others. The increasing demand for pharmaceutical intermediates is due to the growing number of people suffering from chronic diseases such as diabetes and cancer. In addition, the increase in population will also lead to an increase in demand for pharmaceutical intermediates which will further drive the growth of this market during the forecast period.
The global aminopiperidine market has been segmented on basis of type into purity 97%, purity 98%, and purity 99%. Purity 97% accounted for a major share in 2018 owing to its low cost compared with other types. Purity 98% accounted for a major share in 2018 owing to its high quality compared with other types. Purity 99% accounted for a major share in 2018 owing to its high quality compared with other types and low cost when compared with purity 98%. On basis of application, it has been segmented into chemical reagents and pharmaceutical intermediates; while on basis of region it has been segmented into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). North America was estimated as leading region followed by Europe during 2018 due to higher consumption rates among these regions than others regions globally.
- 3-Aminopiperidine is used in the manufacture of pharmaceuticals, pesticides, and other chemicals.
- 3-Aminopiperidine is used as a precursor to other chemical compounds such as pyrrolidines and aminomethylpyrrolidines.
- The global population growth will increase the demand for food production which will lead to an increased demand for pesticides which will lead to an increased demand for 3-aminopiperidine.
- The increasing number of people living with chronic diseases such as diabetes and cancer will increase the need for pharmaceuticals which will lead to an increased need for 3-aminopiperidine.
- Increasing research into new drugs that use 3-aminopiperidine as a starting material or intermediate compound may also contribute to market growth.
Industry Growth Insights published a new data on “3-Aminopiperidine Market”. The research report is titled “3-Aminopiperidine Market research by Types (Purity 97%, Purity 98%, Purity 99%), By Applications (Chemical Reagents, Pharmaceutical Intermediates, Other), By Players/Companies NovoChemy, TCI, 3B Scientific, AlliChem, Waterstone Technology, Shanghai Boyle Chemical, J & K SCIENTIFIC, Shanghai Hanhong Scientific, Guangzhou Isun Pharmaceutical, Chengdu Firster Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
3-Aminopiperidine Market Research Report
By Type
Purity 97%, Purity 98%, Purity 99%
By Application
Chemical Reagents, Pharmaceutical Intermediates, Other
By Companies
NovoChemy, TCI, 3B Scientific, AlliChem, Waterstone Technology, Shanghai Boyle Chemical, J & K SCIENTIFIC, Shanghai Hanhong Scientific, Guangzhou Isun Pharmaceutical, Chengdu Firster Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global 3-Aminopiperidine Market Report Segments:
The global 3-Aminopiperidine market is segmented on the basis of:
Types
Purity 97%, Purity 98%, Purity 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chemical Reagents, Pharmaceutical Intermediates, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- NovoChemy
- TCI
- 3B Scientific
- AlliChem
- Waterstone Technology
- Shanghai Boyle Chemical
- J & K SCIENTIFIC
- Shanghai Hanhong Scientific
- Guangzhou Isun Pharmaceutical
- Chengdu Firster Pharmaceutical
Highlights of The 3-Aminopiperidine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 97%
- Purity 98%
- Purity 99%
- By Application:
- Chemical Reagents
- Pharmaceutical Intermediates
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 3-Aminopiperidine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
3-Aminopiperidine is a synthetic opioid analgesic. It is an analogue of the natural opioid morphine and has similar effects on the body, including reducing pain.
Some of the major players in the 3-aminopiperidine market are NovoChemy, TCI, 3B Scientific, AlliChem, Waterstone Technology, Shanghai Boyle Chemical, J & K SCIENTIFIC, Shanghai Hanhong Scientific, Guangzhou Isun Pharmaceutical, Chengdu Firster Pharmaceutical.
The 3-aminopiperidine market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. 3-Aminopiperidine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. 3-Aminopiperidine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. 3-Aminopiperidine Market - Supply Chain
4.5. Global 3-Aminopiperidine Market Forecast
4.5.1. 3-Aminopiperidine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. 3-Aminopiperidine Market Size (000 Units) and Y-o-Y Growth
4.5.3. 3-Aminopiperidine Market Absolute $ Opportunity
5. Global 3-Aminopiperidine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. 3-Aminopiperidine Market Size and Volume Forecast by Type
5.3.1. Purity 97%
5.3.2. Purity 98%
5.3.3. Purity 99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global 3-Aminopiperidine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. 3-Aminopiperidine Market Size and Volume Forecast by Application
6.3.1. Chemical Reagents
6.3.2. Pharmaceutical Intermediates
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global 3-Aminopiperidine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. 3-Aminopiperidine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global 3-Aminopiperidine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. 3-Aminopiperidine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global 3-Aminopiperidine Demand Share Forecast, 2019-2029
9. North America 3-Aminopiperidine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America 3-Aminopiperidine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America 3-Aminopiperidine Market Size and Volume Forecast by Application
9.4.1. Chemical Reagents
9.4.2. Pharmaceutical Intermediates
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America 3-Aminopiperidine Market Size and Volume Forecast by Type
9.7.1. Purity 97%
9.7.2. Purity 98%
9.7.3. Purity 99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America 3-Aminopiperidine Demand Share Forecast, 2019-2029
10. Latin America 3-Aminopiperidine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America 3-Aminopiperidine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America 3-Aminopiperidine Market Size and Volume Forecast by Application
10.4.1. Chemical Reagents
10.4.2. Pharmaceutical Intermediates
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America 3-Aminopiperidine Market Size and Volume Forecast by Type
10.7.1. Purity 97%
10.7.2. Purity 98%
10.7.3. Purity 99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America 3-Aminopiperidine Demand Share Forecast, 2019-2029
11. Europe 3-Aminopiperidine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe 3-Aminopiperidine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe 3-Aminopiperidine Market Size and Volume Forecast by Application
11.4.1. Chemical Reagents
11.4.2. Pharmaceutical Intermediates
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe 3-Aminopiperidine Market Size and Volume Forecast by Type
11.7.1. Purity 97%
11.7.2. Purity 98%
11.7.3. Purity 99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Gowth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe 3-Aminopiperidine Demand Share, 2019-2029
12. Asia Pacific 3-Aminopiperidine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific 3-Aminopiperidine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific 3-Aminopiperidine Market Size and Volume Forecast by Application
12.4.1. Chemical Reagents
12.4.2. Pharmaceutical Intermediates
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific 3-Aminopiperidine Market Size and Volume Forecast by Type
12.7.1. Purity 97%
12.7.2. Purity 98%
12.7.3. Purity 99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific 3-Aminopiperidine Demand Share, 2019-2029
13. Middle East & Africa 3-Aminopiperidine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa 3-Aminopiperidine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa 3-Aminopiperidine Market Size and Volume Forecast by Application
13.4.1. Chemical Reagents
13.4.2. Pharmaceutical Intermediates
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa 3-Aminopiperidine Market Size and Volume Forecast by Type
13.7.1. Purity 97%
13.7.2. Purity 98%
13.7.3. Purity 99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa 3-Aminopiperidine Demand Share, 2019-2029
14. Competition Landscape
14.1. Global 3-Aminopiperidine Market: Market Share Analysis
14.2. 3-Aminopiperidine Distributors and Customers
14.3. 3-Aminopiperidine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. NovoChemy
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. TCI
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. 3B Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AlliChem
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Waterstone Technology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Shanghai Boyle Chemical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. J & K SCIENTIFIC
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shanghai Hanhong Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Guangzhou Isun Pharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chengdu Firster Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
